Lijuan Ding
No.79 Qingchun Road
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Gut Microbiome Drives Endogenous T Cell Activation Following CAR-T Cell Therapy.
Journal: Cancer immunology research
Published: October 07, 2025
MEK inhibition prevents CAR-T cell exhaustion and differentiation via downregulation of c-Fos and JunB.
Journal: Signal transduction and targeted therapy
Published: November 27, 2023
Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients.
Journal: Frontiers in oncology
Published: December 04, 2021
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 11, 2021
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion.
Journal: Journal of hematology & oncology
Published: April 29, 2021
Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell Leukemia.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 22, 2020
Novel progresses of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma.
Journal: Stem cell investigation
Published: June 27, 2020
Haploinsufficiency of NR3C1 drives glucocorticoid resistance in adult acute lymphoblastic leukemia cells by down-regulating the mitochondrial apoptosis axis, and is sensitive to Bcl-2 blockage.
Journal: Cancer cell international
Published: March 14, 2019
Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapy.
Journal: Bone marrow transplantation
Published: November 13, 2018
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia.
Journal: Experimental hematology & oncology
Published: February 25, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026